Clinical Significance of Cavity Obliteration Following Treatment in Patients With Mycobacterium Avium Complex Pulmonary Disease

被引：0
|
作者：
Kim, J. [1 ]
Bae, J. [2 ]
Hyung, K. [3 ]
Lee, I. [1 ]
Park, H. [1 ]
Kim, S. [4 ]
Lee, K. [1 ]
Ahn, Y. [1 ]
Yoon, S. [1 ]
Kwak, N. [5 ]
Yim, J. [1 ]
机构：
[1] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Seoul, South Korea
[2] Seoul Natl Univ Hosp, Dept Pulmonol & Crit Care Med, Seoul, South Korea
[3] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
[5] Seoul Natl Univ Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Seoul, South Korea
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5180
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Significance of changes in cavity after treatment in Mycobacterium avium complex pulmonary disease
    Kim, Joong-Yub
    Bae, Juye
    Hyung, Kwonhyung
    Lee, Inhan
    Park, Hyun-Jun
    Kim, So Yeon
    Lee, Kyung-Eui
    Ahn, Yoon Hae
    Yoon, Si Mong
    Kwak, Nakwon
    Yim, Jae-Joon
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [2] Treatment of Mycobacterium avium Complex Pulmonary Disease
    Kwon, Yong-Soo
    Koh, Won-Jung
    Daley, Charles L.
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2019, 82 (01) : 15 - 26
  • [3] Treatment of Mycobacterium avium complex pulmonary disease
    Jhun, Byung Woo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (01): : 19 - 25
  • [4] Drug-drug interactions of clinical significance in the treatment of patients with Mycobacterium avium complex disease
    Kuper, JJ
    D'Aprile, M
    CLINICAL PHARMACOKINETICS, 2000, 39 (03) : 203 - 214
  • [5] Drug-Drug Interactions of Clinical Significance in the Treatment of Patients with Mycobacterium avium Complex Disease
    Jeffrey J. Kuper
    Michelle D’Aprile
    Clinical Pharmacokinetics, 2000, 39 : 203 - 214
  • [6] Mycobacterium avium complex pulmonary disease patients with limited treatment options
    Aliberti, Stefano
    Blasi, Francesco
    Burgel, Pierre-Regis
    Calcagno, Andrea
    Floe, Andreas
    Grogono, Dorothy
    Papavasileiou, Apostolos
    Polverino, Eva
    Prados, Concepcion
    Rohde, Gernot
    Salzer, Helmut J. F.
    Sanchez-Montalva, Adrian
    Shteinberg, Michal
    Van Braeckel, Eva
    van Ingen, Jakko
    Veziris, Nicolas
    Wagner, Dirk
    Loebinger, Michael R.
    ERJ OPEN RESEARCH, 2024, 10 (01)
  • [7] Treatment of pulmonary disease caused by Mycobacterium avium complex
    Shimokata, K
    INTERNAL MEDICINE, 2003, 42 (08) : 627 - 628
  • [8] Clinical characteristics of pulmonary Mycobacterium avium complex disease in patients with interstitial lung disease
    Watanabe, Masayuki
    Hagiwara, Eri
    Shintani, Ryota
    Hiramatsu, Yuri
    Ikeda, Satoshi
    Okuda, Ryo
    Sekine, Akimasa
    Baba, Tomohisa
    Komatsu, Shigeru
    Ogura, Takashi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2025, 31 (01)
  • [9] Mycobacterium avium complex pulmonary disease in immunocompetent patients
    Chitty, SA
    Ali, J
    SOUTHERN MEDICAL JOURNAL, 2005, 98 (06) : 646 - 652
  • [10] Clinical characteristics and prevalence of pneumothorax in patients with pulmonary Mycobacterium avium complex disease
    Hagiwara, Eri
    Komatsu, Shigeru
    Nishihira, Ryuichi
    Shinohara, Takeshi
    Baba, Tomohisa
    Ogura, Takashi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (04) : 588 - 592
12345